Abstract
The feasibility of modifying by beam-plasma treatment the biological activity of substances classified with amino acids and proteins was examined, and a possibility for controlling the modification process by varying treatment conditions was shown. An untreated synthetic alanine derivative did not affect platelet aggregation. After plasma treatment, the modification product of the alanine derivative reduced the platelet activity by more than a factor of 2. The products of modification of a fibrin monomer decreased the platelet aggregation by a factor of 1.5 on average, whereas the untreated fibrin monomer had no effect on the process.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
